Cost-Effectiveness Analysis of Direct Oral Anticoagulants Vs. Vitamin K Antagonists in the Elderly With Atrial Fibrillation: Insights From the Evidence in a Real-World Setting

Benzer Materyaller

• Direct Oral Anticoagulants vs. Vitamin-K Antagonists in the Elderly With Atrial Fibrillation: A Systematic Review Comparing Benefits and Harms Between Observational Studies and Randomized Controlled Trials
  Yazar:: Shen, Nan-Nan, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Comparison of effectiveness and safety of direct oral anticoagulants versus vitamin-k antagonists in elderly patients with atrial fibrillation: a systematic review and cost-effectiveness analysis protocol
  Yazar:: Wang, Na, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Direct Oral Anticoagulants vs. Vitamin-K Antagonists in the Elderly With Atrial Fibrillation: A Systematic Review Comparing Benefits and Harms Between Observational Studies and Randomized Controlled Trials
  Yazar:: Nan-Nan Shen, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-09-01)
• Risk of cognitive impairment with non-vitamin K antagonist oral anticoagulants in atrial fibrillation: Protocol for a systemic review of randomized controlled trials and real-world studies
  Yazar:: Shen, Long, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Real-world comparison of non-vitamin K antagonist oral anticoagulants and warfarin in Asian octogenarian patients with atrial fibrillation
  Yazar:: Kwon, Chang Hee, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)